VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an all-cash public tender offer to acquire all outstanding shares in VectivBio for USD 17 per share, with an estimated aggregate consideration […]
Inmarsat, a world leader in global, mobile satellite communications, has announced that SWISSto12, one of Europe’s fastest growing aerospace providers, will develop its new eighth-generation of spacecraft. The three I-8 satellites will provide additional
AURELIUS, the alternative investment group, has announced last April the sale of Distrelec Group, a UK-based B2B distributor of electronic and technical components, to RS Group, a UK-based omni-channel provider of industrial product and
ITS Kanal Services acquired Restclean, a specialist in the field of WC cleaning and renovation. The Swiss ITS Kanal Services is a full-service provider for the maintenance and value preservation of sewer systems and surfaces.
Banking & Finance
Corporate
Tech
Homburger: wefox revolving credit facility and a Series D extension
Wefox the Berlin-based insurtech company, has secured a EUR 50 m revolving credit facility arranged by J.P. Morgan Securities and Barclays Bank, following a USD 55 m second close in its Series D that was completed
Everon, the Zurich-based fintech company, has successfully closes its CHF 2.5m Seed Financing Round led by TX Ventures, the VC investment arm of the Swiss media company TX Group. Other investors include venture capital firm
ANYbotics, a renowned maker of four-legged robots, announced the closing of its CHF 45 million series B financing round. The financing round was led by Walden Catalyst Ventures and included the participation of the co-investors NGP
NKF advised Ecorobotix as Swiss counsel on its CHF 46 million Series B Prime financing round led by AQTON Private Equity and Cibus Capital. Additional investments came from Swisscanto Invest/Swisscanto Growth Fund I, Yara Growth
NewBiologix, a technology company developing a proprietary platform focused on engineering cell lines used to manufacture gene and cell therapies, raised USD 50 million in series A financing. The round was led by Recipharm (an EQT
GAM Holding has entered into an agreement with Liontrust Asset Management relating to the launch by Liontrust of a public exchange offer for all publicly held shares in GAM. As further set out in the
